Costello Medical
  • What We Do
    • Evidence Development
      • Health Economics
      • Statistics
      • Literature Reviews & Synthesis
      • Real-World Evidence
    • Value & Access
      • Market Access
      • HTA
    • Medical Communications
      • Medical Affairs
      • Publications
      • Creative
    • Health Policy & Public Affairs
      • Health Policy
      • Patient Engagement
      • Public Sector
    • MedTech
    • Rare Diseases
    • Gene Therapy
  • Research
    • Articles & Publications
  • Giving Back
    • Pro Bono
    • Global Health Internship
  • Careers
    • Working at Costello Medical
    • Current Vacancies
    • Locations
    • FAQs
  • About Us
    • Team
    • B Corp
  • Contact

When Does a Treatment Effect Really Stop? Exploration of Different Methods for Modelling Treatment Waning

When Does a Treatment Effect Really Stop? Exploration of Different Methods for Modelling Treatment Waning

  • ISPOR Washington 2022
  • Sep 2022
  • ISPOR
  • NICE
  • US
Adoption of Piecewise Modelling: A Review of NICE Health Technology Appraisals in Oncology

Adoption of Piecewise Modelling: A Review of NICE Health Technology Appraisals in Oncology

  • ISPOR Washington 2022
  • Sep 2022
  • ISPOR
  • NICE
  • US
Healthcare Resource Use of People who use Illicit Opioids in England: A Retrospective Cohort Study Using Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES)

Healthcare Resource Use of People who use Illicit Opioids in England: A Retrospective Cohort Study Using Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES)

  • ISPOR Virtual Europe 2021
  • Sep 2022
  • EU
  • ISPOR
Capturing The Value Of Potentially Curative Oncology Therapies: Lessons From The Use And Acceptance Of Cure Modelling Assumptions In NICE Technology Appraisals

Capturing The Value Of Potentially Curative Oncology Therapies: Lessons From The Use And Acceptance Of Cure Modelling Assumptions In NICE Technology Appraisals

  • ISPOR Virtual Europe 2021
  • Sep 2022
  • EU
  • ISPOR
  • NICE
Orphan Drug Compassionate Use Programmes: Impact on Reimbursement Decisions in France, Germany and England

Orphan Drug Compassionate Use Programmes: Impact on Reimbursement Decisions in France, Germany and England

  • ISPOR Virtual Europe 2021
  • Sep 2022
  • EU
  • ISPOR
  • NICE
When Does a Treatment Effect Really Stop? Exploration of Different Methods for Modelling Treatment Waning

When Does a Treatment Effect Really Stop? Exploration of Different Methods for Modelling Treatment Waning

  • ISPOR US 2022
  • Jun 2022
  • HTA
  • ISPOR
  • NICE
  • NSCLC
  • US
Adoption of Piecewise Modelling: A Review of NICE Health Technology Appraisals in Oncology

Adoption of Piecewise Modelling: A Review of NICE Health Technology Appraisals in Oncology

  • ISPOR US 2022
  • Jun 2022
  • HTA
  • ISPOR
  • NICE
  • Oncology
  • US
Investigating Potential Market Failure with Curative Cell and Gene Therapies

Investigating Potential Market Failure with Curative Cell and Gene Therapies

  • ISPOR Milan 2020
  • Feb 2021
  • Cell and Gene Therapy
  • EMA
  • FDA
  • ISPOR
Orphan Drug Compassionate Use Programmes: Scale of Use and Association with Regulatory and Reimbursement Decisions in France, Germany and the UK

Orphan Drug Compassionate Use Programmes: Scale of Use and Association with Regulatory and Reimbursement Decisions in France, Germany and the UK

  • ISPOR Milan 2020
  • Feb 2021
  • ISPOR
  • Rare Diseases
  • Real-World Evidence
Probabilistic Cost-Effectiveness Results and Managed Access Agreements: A Review of Therapies Entering the Cancer Drugs Fund in England

Probabilistic Cost-Effectiveness Results and Managed Access Agreements: A Review of Therapies Entering the Cancer Drugs Fund in England

  • ISPOR Milan 2020
  • Feb 2021
  • ISPOR
  • NICE
  • Oncology
Approaches to the Collection of Utility Values for Rare Diseases: A Cross-Country Comparison

Approaches to the Collection of Utility Values for Rare Diseases: A Cross-Country Comparison

  • ISPOR Milan 2020
  • Feb 2021
  • HTA
  • ISPOR
  • NICE
  • Rare Diseases
  • Utility Values
Trends in Patient-Focused Presentations at Scientific Congresses: A European Rheumatology Congress Case Study

Trends in Patient-Focused Presentations at Scientific Congresses: A European Rheumatology Congress Case Study

  • ISMPP EU 2020
  • Jan 2020
  • 2020
  • Congresses
  • EU
  • ISMPP
  • Patients
  • Publications
  • 1/6
  • View All
What We Do
  • Evidence Development
  • Value & Access
  • Medical Communications
  • Health Policy & Public Affairs
  • MedTech
  • Rare Diseases
  • Gene Therapy
Quick Links
  • Privacy Notice
  • Cookie Policy
  • Manage Cookies
Get In Touch

To request a quotation or for any general enquiries about our services, please fill in our service request form.

Sophie Costello, Director & CEO
T: +44 (0)1223 913 020
sophie.costello@costellomedical.com

  • LinkedIn
  • Web Design by the Costello Medical Creative Team

  • © 2023 Costello Medical Consulting Limited
    VAT Number: 942 1421 53. Company Number: 06746770. Registered in England and Wales.
    Costello Medical® is a registered trade mark of Costello Medical Consulting Limited

  • Scroll to top
Loading
  • What We Do
    • Evidence Development
      • Health Economics
      • Statistics
      • Literature Reviews & Synthesis
      • Real-World Evidence
    • Value & Access
      • Market Access
      • HTA
    • Medical Communications
      • Medical Affairs
      • Publications
      • Creative
    • Health Policy & Public Affairs
      • Health Policy
      • Patient Engagement
      • Public Sector
    • MedTech
    • Rare Diseases
    • Gene Therapy
  • Research
    • Articles & Publications
  • Giving Back
    • Pro Bono
    • Global Health Internship
  • Careers
    • Working at Costello Medical
    • Current Vacancies
    • Locations
    • FAQs
  • About Us
    • Team
    • B Corp
  • Contact

Costello Medical would like to set Google Analytics cookies to collect information on how you use our website to help us to improve it. The cookies collect information in a way that does not directly identify you. For more information, please see ourĀ Privacy Policy.

Privacy Overview
Costello Medical

Our website uses cookies to distinguish you from other users. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. Cookies are files saved on your phone, tablet or computer generated when you visit a website and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. The cookies collect information in a way that does not directly identify you. For full details, please see our Privacy Policy.

3rd Party Cookies

We use a set of third party tools to provide information of how our users engage with our website so that we can improve the experience of the website for our users. For example, we collect information about which of our pages are most frequently visited, and by which types of users. We also use third-party cookies to help with performance.